CWBR News and Press, CohBar Inc. From 05/13/22

CohBar (NASDAQ:CWBR) Q1 consensus EPS estimate is -$0.07 and consensus revenue estimate is $0M. CWBR is scheduled to announce Q1 earnings results on Friday, May 13, after market close. For further details see: CohBar Q1 2022 Earnings Preview

CohBar (NASDAQ:CWBR) said Thursday Nasdaq granted its request for a 180-day extension, or till Nov. 7, to regain compliance with its minimum bid price rule. At its annual shareholder meeting on Jun. 15, CWBR will seek approval for a potential 1-for-30 reverse stock split, with the exact ratio...

MENLO PARK, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chr...

MENLO PARK, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases,...

CohBar, Inc. (CWBR) Q4 2021 Earnings Conference Call March 29 2022, 05:00 PM ET Company Participants Jordyn Tarazi - Director of IR Joe Sarret - CEO and Director Nick Vlahakis - Chief Medical Officer Jeff Biunno - CFO Kent Grindstaff - SVP, Research Conference Call Participants Kristen Kluska...

CohBar press release (NASDAQ:CWBR): Q4 GAAP EPS of -$0.04 beats by $0.01. The company had cash and investments of $26.2 million as of December 31, 2021, compared to $21.0 million as of December 31, 2020. The cash burn for the quarter ended December 31, 2021 was approximately $3.0 million. Sha...

MENLO PARK, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related disease...

AMPE, AREC, CALM, CHWY, CRMD, CWBR, CWCO, HTGM, INFI, OTCQB:LQMT, LULU, MLKN, MOTS, MU, MVST, NBRV, NBY, OTC:OIBZQ, OPGN, PAVM, PRGS, PVH, RH, SNDL, SPWH, SUNL, VRNT, ZVO For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesd...

MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related disease...

AAP, ACTG, AESE, OTCPK:AOIFF, DADAASTS, ATHX, AXON, AYTU, BIOC, BITF, CIDM, CMP, OTCQX:CWBHF, CWBR, CWCO, CYBN, DM, DNMR, DRIO, OTCQB:ELTP, ETON, EVFM, GLAD, GNLN, GOEV, IBIO, IDEX, INPX, IONQ, ISUN, LCID, LUNA, MARK, OTCQX:MRMD, MVST, NDRA, NEPT, PLBY, POWW, PRCH, PRPO, QFIN, RKDA,...